-
Product Insights
NewAngiosarcoma – Drugs In Development, 2024
Empower your strategies with our Angiosarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Angiosarcoma is a rare type of cancer that that develops in the inner lining of the blood and lymph vessels and is linked to a gene called POTI. Angiosarcoma appears as a bruise-like lesion that grows over time. Once metastatic, it becomes difficult to treat and the survival rate drops to 12-33%. The Angiosarcoma drugs in development market research report provide comprehensive information...
-
Product Insights
NewCutaneous Angiosarcoma – Drugs In Development, 2024
Empower your strategies with our Cutaneous Angiosarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Cutaneous angiosarcoma (cAS) is a rare and aggressive subtype of soft tissue sarcoma with poor prognosis and suboptimal treatment options. The Cutaneous Angiosarcoma drugs in development market research report provide comprehensive information on the therapeutics under development for Cutaneous Angiosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report...